Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

News

Personalis, Inc. to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019

gbafNews28

Personalis, Inc., a leader in advanced genomics for cancer, today announced that the company will present one oral presentation and five posters at the American Association for Cancer Research (AACR) Annual Meeting being held this year in Atlanta, GA from March 31 “ April 3, 2019.

Personalis presentations will highlight how fundamental oncology research informs the ongoing evolution of our leading immunogenomics analysis platform. The presentations will also detail the alignment between our genomics solutions and AACR’s 2019 theme: Integrative Cancer Science ¢ Global Impact ¢ Individualized Patient Care.

Following is a list of abstracts that will be presented at the meeting.

             
Presentation #   Title & Presenter   Day & Time   Location
MS.BSB01.01 905 (Oral Presentation)  

Comprehensive immunogenomic profiling of anti-PD-1 treated melanoma patients reveals subject-specific tumor escape mechanisms

  March 31 3:05 pm-3:20 pm   Room B206
PO.MCB09.04 2512 / 8  

A comprehensive genomics platform for precision immunotherapy: Simultaneously characterizing the tumor and tumor microenvironment from a single FFPE sample

  April 1 1-5pm   Poster section 33
PO.BSB01.01 3377/8  

T-cell receptor repertoire profiling using an augmented transcriptome

  April 2 8 am-12 pm   Poster section 31
PO.TB11.02 3788 / 5  

Sensitive detection of oncoviruses integrated into a comprehensive tumor immuno-genomics platform

  April 2 1 pm-5 pm   Poster section 8
PO.CH03.01 4536 / 9  

Applying Immuno-Peptidomics and Machine Learning to Improve Neoantigen Prediction for Therapeutic and Diagnostic Use

  April 3 8 am-12 pm   Poster section 2
PO.TB10.03 4695 / 8  

Development and Validation of an Accurate Exome-Scale cfDNA Detection Platform

  April 3 8 am-12 pm   Poster section 9

About Personalis, Inc.

Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patients cancer and immune response. The companys NeXT Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).

Jennifer Havlek
pr@personalis.com
www.personalis.com
650-752-1300

Advertisement
Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now

Recommended

Global Banking & Finance Review® is a leading financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management. Copyright © 2010-2021 GBAF Publications Ltd - All Rights Reserved.